文献速递细菌感染、耐药与抗菌药物发热待查

抗菌药物耐药加剧时代肠热症的治疗反应:尼泊尔4项随机对照试验2092例个体患者数据分析

Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal.
PubMed 文献 · Clin Infect Dis · 2017-01-01

该研究汇总尼泊尔加德满都4项随机对照试验中2092例肠热症患者的个体数据,比较加替沙星与头孢克肟、氯霉素、氧氟沙星或头孢曲松的疗效。结果显示,除最后一项头孢曲松试验外,加替沙星退热时间相当或更短、治疗失败率更低;但氟喹诺酮类最低抑菌浓度自2005年起显著上升并与退热时间延长相关,所有菌株对头孢曲松敏感、阿奇霉素MIC下降。作者建议基于此证据修改南亚氟喹诺酮类推荐政策。

要点

  • 加替沙星在多数试验中退热时间相当或更短、治疗失败率更低。
  • 氟喹诺酮类MIC自2005年起显著上升,与退热时间延长相关。
  • 所有菌株对头孢曲松敏感,阿奇霉素MIC下降。

核心结论

  • 世界卫生组织与南亚地方政府卫生部仍推荐氟喹诺酮类治疗肠热症,但基于本证据该政策应改变。
  • 鉴于大量疑似肠热症患者血培养阴性,迫切需要快速诊断方法。

研究设计与样本

  • 汇总尼泊尔加德满都4项随机对照试验中2092例肠热症患者的个体数据。
  • 所有试验均比较加替沙星与以下一种对照药:头孢克肟、氯霉素、氧氟沙星或头孢曲松。
  • 依据血培养分离出伤寒沙门菌或甲型副伤寒沙门菌的患者评估抗菌药物治疗结局,并分析细菌抗菌药物敏感性变化对结局的影响。

主要发现

  • 855例(41%)患者血培养阳性,其中伤寒沙门菌581例(28%)、甲型副伤寒沙门菌274例(13%)。
  • 共139例(6.6%)治疗失败,1例死亡。
  • 除最后一项头孢曲松试验外,氟喹诺酮类加替沙星与其他所有抗菌药物相比退热时间相当或更短、治疗失败率更低。
  • 氟喹诺酮类最低抑菌浓度自2005年起显著上升,并与退热时间延长相关。
  • 研究期间(2005-2014年)所有菌株对头孢曲松敏感,阿奇霉素最低抑菌浓度下降。

临床怎么用

  • 南亚肠热症经验性治疗应考虑当地氟喹诺酮类耐药上升趋势,头孢曲松和阿奇霉素仍可作为替代药物。
  • 对疑似肠热症而血培养阴性的大批患者,需依赖快速诊断手段指导治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND.: Enteric fever, caused by Salmonella Typhi and Salmonella Paratyphi A, is the leading cause of bacterial febrile disease in South Asia. METHODS.: Individual data from 2092 patients with enteric fever randomized into 4 trials in Kathmandu, Nepal, were pooled. All trials compared gatifloxacin with 1 of the following comparator drugs: cefixime, chloramphenicol, ofloxacin, or ceftriaxone. Treatment outcomes were evaluated according to antimicrobial if S. Typhi/Paratyphi were isolated from blood. We additionally investigated the impact of changing bacterial antimicrobial susceptibility on outcome. RESULTS.: Overall, 855 (41%) patients had either S. Typhi (n = 581, 28%) or S. Paratyphi A (n = 274, 13%) cultured from blood. There were 139 (6.6%) treatment failures with 1 death. Except for the last trial with ceftriaxone, the fluoroquinolone gatifloxacin was associated with equivalent or better fever clearance times and lower treatment failure rates in comparison to all other antimicrobials. However, we additionally found that the minimum inhibitory concentrations (MICs) against fluoroquinolones have risen significantly since 2005 and were associated with increasing fever clearance times. Notably, all organisms were susceptible to ceftriaxone throughout the study period (2005-2014), and the MICs against azithromycin declined, confirming the utility of these alternative drugs for enteric fever treatment. CONCLUSION.: The World Health Organization and local government health ministries in South Asia still recommend fluoroquinolones for enteric fever. This policy should change based on the evidence provided here. Rapid diagnostics are urgently required given the large numbers of suspected enteric fever patients with a negative culture.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Thompson CN, Karkey A, Dongol S, et al. Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal. Clin Infect Dis. 2017. PMID: 28329181. doi:10.1093/cid/cix185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。